Skip to main content
    Paid monthly and annual subscribers can read every Medi-Chi book online — including clinical references and the TCM Textbook · downloads sold separatelySee the libraryClinical Education Tool — This platform provides educational resources for TCM practitioners and students. It does not issue medical certificates, prescriptions, or clinical diagnoses.
    respiratory

    Chronic refractory breathlessness

    Also known as: Chronic breathlessness, Refractory dyspnoea, Persistent breathlessness, Chronic refractory dyspnoea

    Chronic refractory breathlessness persists despite optimal management of underlying disease, including advanced respiratory disease, heart disease, or malignancy. New deterioration requires reassessment rather than attribution to a chronic symptom. Management remains disease-directed and may include multidisciplinary symptom support and clinician-supervised palliation. Evidence regarding opioid administration indicates low-quality support for benefit alongside significant adverse effects. Fan therapy has not demonstrated significant overall efficacy, although post hoc subgroup analyses suggest potential short-term relief. As current evidence does not establish the efficacy of acupuncture or Chinese herbal medicine for this condition, TCM pattern assessment may inform individually negotiated adjunctive supportive care, without replacing respiratory, cardiac, oncology, or palliative care.

    Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.

    All clinical details on this page are for practitioner premium subscribers only.
    Checking your practitioner access
    Verifying your Medi-Chi access…

    Lifestyle & Diet

    • •Partition daily activities into manageable stages, incorporating rest periods prior to exhaustion; consult a physiotherapist for a tailored physical activity regimen.
    • •Adopt ergonomic upright or supported forward-leaning postures and perform breathing techniques as prescribed by the medical team.
    • •A handheld fan directed towards the face may offer brief symptomatic comfort; cease use if unpleasant, and note that relief does not indicate improved oxygenation.
    • •Avoid tobacco smoke and respiratory irritants; maintain adherence to all prescribed pharmacological and oxygen therapies, and ensure the acute deterioration action plan is readily accessible.

    Cautions & Contraindications

    See sources
    • •Do not delay medical reassessment or reduce prescribed disease-directed therapy because of a TCM pattern diagnosis. The supplied review frames refractory breathlessness after thorough evaluation and management of underlying illness.[]
    • •Do not initiate, stop or adjust opioids through this guide. Prescriber supervision is necessary because drowsiness, nausea, vomiting and constipation occur; the supplied review does not support nebulised opioids.[]
    • •Defer needling during acute respiratory instability; use supported positioning and avoid unnecessary thoracic needling in patients with limited respiratory reserve. These are general procedural precautions: the supplied management review does not establish acupuncture safety or efficacy.[]
    • •Require medication reconciliation before herbal treatment, particularly with opioids, sedatives, anticoagulants, diuretics or complex cardiac treatment. This is a general interaction precaution; the supplied abstracts do not evaluate herbal interactions.[,]

    When to reassess or seek care again

    See sources

    Record baseline breathlessness intensity and distress on separate 0–10 scales, a patient-selected daily activity, rescue medicine use and adverse effects. Review within 1–2 weeks of starting any adjunct and at each visit for deterioration. Reassess the overall plan by 4 weeks; stop ineffective or burdensome adjuncts if there is no patient-valued improvement. Increasing symptoms, declining function or rising rescue medicine use trigger medical review sooner; red flags require immediate escalation. The supplied multidisciplinary service paper is a protocol with no outcome results and does not validate this review schedule.

    Explore more diseases

    Sources & Further Reading

    Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.

    1. The Cochrane database of systematic reviews · 2016
    2. Journal of clinical nursing · 2026
    3. JMIR research protocols · 2026
    4. Journal of general internal medicine · 2021

    Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.